Log In
BCIQ
Print this Print this
 

AIM-102

  Manage Alerts
Collapse Summary General Information
Company AIM Therapeutics Inc.
DescriptionNon-steroidal anti-inflammatory therapeutic that prevent adhesion of neutrophils
Molecular Target
Mechanism of ActionNSAID
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationAsthma
Indication DetailsTreat asthma
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today